Who owns ACUMEN PHARMACEUTICALS INC?
- Ticker: ABOS
- CUSIP Number: 00509g209
Tip: Access positions for across all investors
Analyze quarterly positions in Acumen Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Acumen Pharmaceuticals stock
Who bought or sold ACUMEN PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 15M | $26M | 0% | Sep 2025 |
|
| Sands Capital Ventures | 3.4M | $5.8M | 0% | Sep 2025 |
|
| Franklin Resources | 2.3M | $3.9M | -25% | Sep 2025 |
|
| FMR | 2.0M | $3.5M | 0% | Sep 2025 |
|
| Vanguard Group | 1.7M | $2.8M | -2% | Sep 2025 |
|
| Knollwood Investment Advisory | 1.6M | $2.8M | 0% | Sep 2025 |
|
| Alyeska Investment Group | 940k | $1.6M | 0% | Sep 2025 |
|
| ADAR1 Capital Management | 891k | $1.5M | -3% | Sep 2025 |
|
| Laurion Capital Management | 867k | $1.5M | 0% | Sep 2025 |
|
| Pathstone Holdings | 859k | $1.5M | -19% | Sep 2025 |
|
| Hudson Bay Capital Management | 725k | $1.2M | -12% | Sep 2025 |
|
| Millennium Management | 602k | $1.0M | -69% | Sep 2025 |
|
| Renaissance Technologies | 584k | $999k | 137% | Sep 2025 |
|
| Citadel Advisors | 506k | $865k | 3436% | Sep 2025 |
|
| Two Sigma Advisers | 424k | $724k | -1% | Sep 2025 |
|
| SG Americas Securities | 404k | $691k | 100% | Sep 2025 |
|
| Geode Capital Management | 399k | $682k | 1% | Sep 2025 |
|
| Ikarian Capital | 266k | $455k | 0% | Sep 2025 |
|
| Susquehanna International | 214k | $367k | 26% | Sep 2025 |
|
| Jane Street | 207k | $354k | 18% | Sep 2025 |
|
| Two Sigma Investments | 199k | $341k | -1% | Sep 2025 |
|
| Bridgeway Capital Management | 190k | $325k | 65% | Sep 2025 |
|
| BlackRock | 175k | $299k | -40% | Sep 2025 |
|
| Morgan Stanley | 154k | $178k | 100% | Jun 2025 |
|
| Goldman Sachs Group | 147k | $252k | -25% | Sep 2025 |
|
| State Street Corporation | 107k | $182k | 0% | Sep 2025 |
|
| Catalyst Financial Partners | 90k | $153k | 0% | Sep 2025 |
|
| Acadian Asset Management | 78k | $131k | 100% | Sep 2025 |
|
| Northern Trust | 65k | $111k | 0% | Sep 2025 |
|
| Boothbay Fund Management | 51k | $87k | 0% | Sep 2025 |
|
| Dimensional Fund Advisors | 44k | $74k | 0% | Sep 2025 |
|
| Qube Research & Technologies | 33k | $56k | -43% | Sep 2025 |
|
| GSA Capital Partners | 32k | $55k | 0% | Sep 2025 |
|
| UBS Group | 31k | $51k | -67% | Sep 2025 |
|
| Intrepid Financial Planning Group | 30k | $52k | 0% | Sep 2025 |
|
| Barclays | 30k | $51k | 0% | Sep 2025 |
|
| Catalyst Funds Management Pty | 30k | $51k | 50% | Sep 2025 |
|
| Cubist Systematic Strategies | 24k | $41k | 100% | Sep 2025 |
|
| Pinnacle Wealth Management Advisory | 18k | $31k | 0% | Sep 2025 |
|
| Gail Mannix | 18k | $31k | 0% | Sep 2025 |
|
| Clune & Associates | 17k | $28k | 0% | Sep 2025 |
|
| Point72 Asia | 16k | $27k | -25% | Sep 2025 |
|
| Jacobs Levy Equity Management | 16k | $27k | 100% | Sep 2025 |
|
| Hrt Financial | 14k | $23k | -55% | Sep 2025 |
|
| PFG Investments | 12k | $20k | 100% | Sep 2025 |
|
| Savant Capital Management | 11k | $19k | 100% | Sep 2025 |
|
| Integrated Wealth Concepts | 10k | $17k | -2% | Sep 2025 |
|
| Group One Trading | 7.8k | $13k | -9% | Sep 2025 |
|
| Advisor Group Holdings | 7.3k | $10k | 0% | Sep 2025 |
|
| Wells Fargo & Company | 6.5k | $11k | -5% | Sep 2025 |
|
| Larson Financial Group | 4.0k | $6.8k | 100% | Sep 2025 |
|
| Pnc Financial Services | 3.1k | $5.3k | -38% | Sep 2025 |
|
| Jpmorgan Chase & Co | 3.0k | $5.3k | -100% | Sep 2025 |
|
| Rockefeller Capital Management | 3.0k | $5.1k | 100% | Sep 2025 |
|
| TFC Financial Management | 2.5k | $4.3k | 100% | Sep 2025 |
|
| NISA Investment Advisors | 1.2k | $2.1k | 0% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 1.2k | $2.1k | -40% | Sep 2025 |
|
| Royal Bank of Canada | 1.1k | $1.6k | 16% | Sep 2025 |
|
| Advisory Services Network | 1.1k | $1.9k | 100% | Sep 2025 |
|
| CWM | 744.00 | $1.0k | -82% | Sep 2025 |
|
| SBI Securities | 518.00 | $885.987200 | 1% | Sep 2025 |
|
| EverSource Wealth Advisors | 407.00 | $696.010700 | -2% | Sep 2025 |
|
| Bell Investment Advisors | 362.00 | $619.997400 | 100% | Sep 2025 |
|
| Farther Finance Advisors | 200.00 | $342.000000 | 0% | Sep 2025 |
|
| SRS Capital Advisors | 26.00 | $43.999800 | 100% | Sep 2025 |
|
| Optiver Holding B.V. | 6.00 | $10.000200 | 100% | Sep 2025 |
|
| NBT Bank | 2.00 | $342.000000 | -99% | Sep 2025 |
|
Who sold out of Acumen Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Y-Intercept | Jun 2025 | 251k | $291k |
| Marshall Wace | Jun 2025 | 138k | $160k |
| AQR Capital Management | Jun 2025 | 46k | $54k |
| Jain Global | Jun 2025 | 40k | $46k |
| Marex Group | Jun 2025 | 33k | $39k |
| Two Sigma Securities | Jun 2025 | 20k | $23k |
| Schonfeld Strategic Advisors | Jun 2025 | 16k | $19k |
| Ethic | Jun 2025 | 11k | $13k |
| DRW Holdings | Jun 2025 | 11k | $13k |
| Tower Research Capital | Jun 2025 | 3.6k | $4.2k |
| Federation des caisses Desjardins du Quebec | Jun 2025 | 1.5k | $1.7k |
| Skopos Labs | Jun 2025 | 619.00 | $719.030400 |
| Raymond James Financial | Jun 2025 | 495.00 | $574.002000 |
| Hartland & Co | Jun 2025 | 63.00 | $73.999800 |
| True Wealth Design | Jun 2025 | 35.00 | $40.999000 |